GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Institutional Ownership

Perseus Proteomics (TSE:4882) Institutional Ownership : 0.53% (As of Jun. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Perseus Proteomics's institutional ownership is 0.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Perseus Proteomics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Perseus Proteomics's Float Percentage Of Total Shares Outstanding is 0.00%.


Perseus Proteomics Institutional Ownership Historical Data

The historical data trend for Perseus Proteomics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Institutional Ownership Chart

Perseus Proteomics Historical Data

The historical data trend for Perseus Proteomics can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53

Perseus Proteomics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Perseus Proteomics (TSE:4882) Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines